APA (7th ed.) Citation

Lehrian, S., Wasynczuk, A., Petry, J., Guderian, M., Nouta, J., Buhre, J. S., . . . Ehlers, M. (2025). Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00708-6

Chicago Style (17th ed.) Citation

Lehrian, Selina, et al. "Anti-tumor Vaccine Efficacy Depends on Adjuvant Type and Associates with Induced IgG Subclass and Glycosylation Profiles." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00708-6.

MLA (9th ed.) Citation

Lehrian, Selina, et al. "Anti-tumor Vaccine Efficacy Depends on Adjuvant Type and Associates with Induced IgG Subclass and Glycosylation Profiles." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00708-6.